Las Vegas, NV -- (SBWIRE) -- 11/12/2012 -- Since the beginning of September when the stock as trading around $0.75 per share TNI BioTech, Inc. (PINK:TNIB) has continued to make explosive gains and just when investors thought the stock could not go any higher, it does!
For many unlucky shorts who smartly shorted TNIB which has little if any fundamentals to back up its $180 million market valuation when the stock broke over $1 this continuing rise has been a nightmare and has already cleaned out many trading accounts.
Currently trading at $7.50 per share TNIB has been on a tear in recent sessions spiking off its $5 highs to incredible new highs.
TNI BioTech is a biotech company combating fatal diseases through the activation and mobilization of the body's immune system using our patented immunotherapy. Their products and immunotherapy technologies are designed to harness the power of the immune system to improve the treatment of cancer, infections such as HIV/AIDS, chronic inflammatory diseases, and autoimmune diseases.
The Company has been making some important announcements in recent months; on October 18 they reported that "TNI BioTech, Inc. and Hubei Qianjiang Pharmaceutical Co., Ltd., announced an agreement to co-develop new cancer drugs based on TNI BioTech's patents involving Methionine Enkephalin which when approved will be marketed in China under the brand name IRT-101 and IRT-102.
OTCMAGIC has recently published a new article on TNIB. To find out more about this stock and what OTCMAGIC projects for TNI BioTech both short term and long term please go here: TNIB
OTCMAGIC Spends all day scouring the markets for the next huge Penny Stock Winner. Investors have come to trust us for our up to date commentary on all hot stocks so please visit OTCMAGIC right now and see what it’s all about for yourself! At 30,000 Visitors a Month and growing rapidly OTCMAGIC is the hottest thing in Penny Stocks!
Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. PLEASE NOTE: OTCMagic.com employees are not registered as an Investment Advisor in any jurisdiction whatsoever. Full disclaimer can be read at http://OTCMagic.com/disclaimer. Release of Liability: Through use of this website viewing or using you agree to hold OTCMagic.com, its operators owners and employees harmless and to completely release them from any and all liability due to any and all loss monetary or otherwise, damage monetary or otherwise, or injury (monetary or otherwise) that you may incur. The information contained herein is based on sources which we believe to be reliable but is not guaranteed by us as being accurate and does not purport to be a complete statement or summary of the available data. OTCMagic.com affiliates may from time to time have a position in the securities mentioned herein and may increase or decrease such positions without notice. Any opinions expressed are subject to change without notice. OTCMagic.com encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and OTCMagic.com. We make no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies. This is not a solicitation to buy or sell any securities. Any claims or Statements should be deemed hypothetical. OTCMagic.com, nor any of its affiliates are not registered investment advisors or broker dealers.
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-321-1250 (International)